A mouse pancreatic organoid model to compare PD-L1 blocking antibodies
Sign Up to like & getrecommendations! Published in 2022 at "mAbs"
DOI: 10.1080/19420862.2022.2139886
Abstract: ABSTRACT Immune checkpoint inhibitors (ICIs) have changed the therapeutic landscape for cancer patients, but diabetes, a rare, severe immune-related endocrinopathy, is linked to ICI therapy. It is unclear whether glycosylation of ICIs may play a… read more here.
Keywords: blocking antibodies; pancreatic organoid; mouse pancreatic; organoid model ... See more keywords